[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100606016":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":10,"centralContacts":10,"locations":10,"responsibleParty":23,"collaborators":10,"id":26,"slug":27,"hasResults":28,"nctId":29,"briefTitle":30,"officialTitle":31,"acronym":10,"eligibilityCriteria":32,"healthyVolunteers":28,"sex":33,"minAge":34,"maxAge":10,"enrollmentInfo":35,"targetDuration":10,"studyType":38,"phases":10,"briefSummary":39,"conditions":40,"keywords":10,"overallStatus":42,"whyStopped":10,"lastUpdateSubmitDate":43,"lastUpdatePostDateStruct":44,"startDateStruct":47,"completionDateStruct":49,"leadSponsor":51,"locationsCount":10},{"fullName":5,"class":6},"The First Affiliated Hospital of Guangzhou Medical University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Vaccination group",null,"Lung cancer patients receive herpes zoster vaccine",[13],"Biological: herpes zoster vaccine",{"label":15,"type":10,"description":16,"interventionNames":10},"Unvaccinated group","Lung cancer patients have not received herpes zoster vaccine",[18],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":10},"BIOLOGICAL","herpes zoster vaccine","Receive the herpes zoster vaccine; Do not receive the herpes zoster vaccine",[9],{"type":24,"investigatorFullName":25,"investigatorTitle":5,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Yalei Zhang","100606016","observational-study-on-the-impact-of-herpes-zoster-vaccine-on-the-incidence-of-herpes-zoster-and-survival-in-lung-cancer-patients-100606016",false,"NCT07170059","Observational Study on the Impact of Herpes Zoster Vaccine on the Incidence of Herpes Zoster and Survival in Lung Cancer Patients","An Observational Study on the Impact of Herpes Zoster Vaccine on the Incidence of Herpes Zoster and Survival in Lung Cancer Patients","Inclusion Criteria:\n\n* 1.Male or female patients \\>=18 years of age; 2.Histological diagnosis of NSCLC, including both non-small cell lung cancer and small cell lung cancer, regardless of whether they are in the early, locally advanced stage or advanced stage, and regardless of whether they have received surgery, radiotherapy, chemotherapy or other treatments; 3. Never received herpes zoster vaccine\n\nExclusion Criteria:\n\n* Patients having other factors that preventing researchers from enrollment them.","ALL","18 Years",{"count":36,"type":37},500,"ESTIMATED","OBSERVATIONAL","To evaluate the impact of herpes zoster vaccine on the incidence of herpes zoster and survival in lung cancer patients, and to explore its preventive effect and safety.",[41],"Lung Cancer","NOT_YET_RECRUITING","2025-09-07",{"date":45,"type":46},"2025-09-12","ACTUAL",{"date":48,"type":37},"2025-10-01",{"date":50,"type":37},"2030-10-01",{"name":5,"class":6}]